233 related articles for article (PubMed ID: 34108036)
1. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
[TBL] [Abstract][Full Text] [Related]
2. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
Mukora R; Maraba N; Orrell C; Jennings L; Naidoo P; Mbatha MT; Velen K; Fielding K; Charalambous S; Chetty-Makkan CM
BMJ Open; 2023 Mar; 13(3):e065202. PubMed ID: 36868589
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
[TBL] [Abstract][Full Text] [Related]
5. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.
Moriarty AS; Louwagie GM; Mdege ND; Morojele N; Tumbo J; Omole OB; Bachmann MO; Kanaan M; Turner A; Parrott S; Siddiqi K; Ayo-Yusuf OA
Trials; 2019 Jul; 20(1):457. PubMed ID: 31349850
[TBL] [Abstract][Full Text] [Related]
6. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
Wei X; Hicks JP; Pasang P; Zhang Z; Haldane V; Liu X; Yin T; Wang L; Shi D; Ge S; Walley J; Upshur R; Hu J
Trials; 2019 May; 20(1):273. PubMed ID: 31097023
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial.
Lewis JJ; Liu X; Zhang Z; Thomas BV; Vassall A; Sweeney S; Caihong X; Dongmei H; Xue L; Yongxin G; Huan S; Shiwen J; Fielding KL
Trials; 2018 Jul; 19(1):398. PubMed ID: 30045757
[TBL] [Abstract][Full Text] [Related]
10. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
11. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
Huang R; Ren G; Hu J
Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
[TBL] [Abstract][Full Text] [Related]
12. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial.
Foster N; Tadesse AW; McQuaid CF; Gosce L; Abdurhman T; Assefa D; Bedru A; Houben RMGJ; van Kalmthout K; Letta T; Mohammed Z; van Rest J; Umeta DG; Weldemichael GT; Yazew H; Jerene D; Quaife M; Fielding KL
Trials; 2023 Apr; 24(1):292. PubMed ID: 37095533
[TBL] [Abstract][Full Text] [Related]
14. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
[TBL] [Abstract][Full Text] [Related]
15. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
[TBL] [Abstract][Full Text] [Related]
16. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
[TBL] [Abstract][Full Text] [Related]
17. Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
Cattamanchi A; Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger C; Tucker A; Patel D; Sammann A; Turyahabwe S; Dowdy D; Katamba A
PLoS Med; 2021 May; 18(5):e1003628. PubMed ID: 33956802
[TBL] [Abstract][Full Text] [Related]
18. Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.
Sahile Z; Perimal-Lewis L; Arbon P; Maeder AJ
PLoS One; 2021; 16(12):e0261758. PubMed ID: 34972128
[TBL] [Abstract][Full Text] [Related]
19. Effect of a brief motivational interview and text message intervention targeting tobacco smoking, alcohol use and medication adherence to improve tuberculosis treatment outcomes in adult patients with tuberculosis: a multicentre, randomised controlled trial of the ProLife programme in South Africa.
Louwagie G; Kanaan M; Morojele NK; Van Zyl A; Moriarty AS; Li J; Siddiqi K; Turner A; Mdege ND; Omole OB; Tumbo J; Bachmann M; Parrott S; Ayo-Yusuf OA
BMJ Open; 2022 Feb; 12(2):e056496. PubMed ID: 35165113
[TBL] [Abstract][Full Text] [Related]
20. Protocol for an evaluation of adherence monitoring and support interventions among people initiating antiretroviral therapy in Cape Town, South Africa-a multiphase optimization strategy (MOST) approach using a fractional factorial design.
Jennings L; West RL; Halim N; Kaiser JL; Gwadz M; MacLeod WB; Gifford AL; Haberer JE; Orrell C; Sabin LL
Trials; 2023 May; 24(1):310. PubMed ID: 37147725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
